Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in the carrying amount of goodwill by reportable operating segment for the six months ended June 30, 2016 are summarized as follows:



	North America		Europe		Asia Pacific			South America		Total
Balance at January 1, 2016	$	114,109	$	11,056	$	24,054		$	—	$	149,219
Acquisition	—		—		3,334			—		3,334
Foreign exchange translation	820		201		(597		)	—		424
Balance at June 30, 2016	$	114,929	$	11,257	$	26,791		$	—	$	152,977

Goodwill is tested for impairment by reporting unit either annually or when events or circumstances indicate that an impairment may exist. There were no indicators of potential impairment during the six months ended June 30, 2016.

The following table presents intangible assets and accumulated amortization balances of the Company as of June 30, 2016 and December 31, 2015, respectively:



	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer relationships	$	115,137	$	(66,938	)	$	48,199
Developed technology	8,915		(8,249		)	666
Other	15,905		(1,441		)	14,464
Balance at June 30, 2016	$	139,957	$	(76,628	)	$	63,329

Customer relationships	$	115,285	$	(61,375	)	$	53,910
Developed technology	8,854		(7,673		)	1,181
Other	16,290		(679		)	15,611
Balance at December 31, 2015	$	140,429	$	(69,727	)	$	70,702

Amortization expense totaled $3,239 and $3,672 for the three months ended June 30, 2016 and 2015, respectively, and $6,517 and $7,220 for the six months ended June 30, 2016 and 2015, respectively. Amortization expense is estimated to be approximately $12,800 for the year ending December 31, 2016.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details